Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Exxon Mobil
XOM
|
$527M |
| 2 |
Becton Dickinson
BDX
|
$410M |
| 3 |
Intuitive Surgical
ISRG
|
$369M |
| 4 |
GE Aerospace
GE
|
$316M |
| 5 |
IBM
IBM
|
$308M |
Top Sells
| 1 |
NetEase
NTES
|
$499M |
| 2 |
BCR
CR Bard Inc.
BCR
|
$455M |
| 3 |
Medtronic
MDT
|
$401M |
| 4 |
NVIDIA
NVDA
|
$339M |
| 5 |
Netflix
NFLX
|
$331M |
Sector Composition
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.75% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.64% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $876M | 0.97% | 14,302,900 +3,456,300 | +32% | +$212M |
|
2
Novo Nordisk
NVO
$251B
| $844M | 0.93% | 15,731,200 +1,369,900 | +10% | +$73.5M |
|
|
3
Exxon Mobil
XOM
$487B
| $832M | 0.92% | 9,948,354 +6,295,900 | +172% | +$527M |
|
4
Humana
HUM
$36.5B
| $804M | 0.89% | 3,241,700 -418,400 | -11% | -$104M |
|
5
Amgen
AMGN
$155B
| $796M | 0.88% | 4,579,445 +661,745 | +17% | +$115M |
|
6
VeriSign
VRSN
$25.5B
| $781M | 0.86% | 6,826,054 +916,278 | +16% | +$105M |
|
7
PepsiCo
PEP
$204B
| $779M | 0.86% | 6,497,262 +996,562 | +18% | +$120M |
|
8
Colgate-Palmolive
CL
$67.9B
| $649M | 0.72% | 8,601,900 -1,002,200 | -10% | -$75.6M |
|
9
Palo Alto Networks
PANW
$127B
| $635M | 0.7% | 4,379,100 +681,200 | +18% | +$98.7M |
|
10
Domino's
DPZ
$15.6B
| $621M | 0.68% | 3,286,400 +64,100 | +2% | +$12.1M |
|
11
Home Depot
HD
$405B
| $617M | 0.68% | 3,255,400 +602,600 | +23% | +$114M |
|
12
Philip Morris
PM
$260B
| $608M | 0.67% | 5,753,131 +2,779,331 | +93% | +$294M |
|
13
Crown Castle
CCI
$43.2B
| $599M | 0.66% | 5,395,800 +481,800 | +10% | +$53.5M |
|
14
Align Technology
ALGN
$10.3B
| $581M | 0.64% | 2,614,100 +576,900 | +28% | +$128M |
|
15
Cboe Global Markets
CBOE
$24.7B
| $563M | 0.62% | 4,520,000 +130,300 | +3% | +$16.2M |
|
16
Gilead Sciences
GILD
$140B
| $542M | 0.6% | 7,564,948 -2,665,951 | -26% | -$191M |
|
|
17
Intuitive Surgical
ISRG
$170B
| $526M | 0.58% | 1,440,600 +1,012,000 | +236% | +$369M |
|
18
Johnson & Johnson
JNJ
$427B
| $485M | 0.53% | 3,469,800 -836,400 | -19% | -$117M |
|
|
19
IBM
IBM
$227B
| $478M | 0.53% | 3,115,200 +2,007,513 | +181% | +$308M |
|
|
20
Becton Dickinson
BDX
$55.3B
| $444M | 0.49% | 2,074,503 +1,913,952 | +1,192% | +$410M |
|
|
21
NVIDIA
NVDA
$4.24T
| $437M | 0.48% | 2,256,293 -1,753,807 | -44% | -$339M |
|
|
22
NetEase
NTES
$86.2B
| $427M | 0.47% | 1,238,100 -1,444,950 | -54% | -$499M |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $427M | 0.47% | 2,847,917 +1,479,897 | +108% | +$222M |
|
|
24
GE Aerospace
GE
$292B
| $427M | 0.47% | 24,454,964 +18,103,724 | +285% | +$316M |
|
25
Walmart
WMT
$774B
| $412M | 0.45% | 4,172,313 -1,870,687 | -31% | -$185M |
|